US Non-Invasive Aesthetic Treatment Market (By Procedure: Injectable, Skin Rejuvenation, Others; By End Use: Hospitals & Surgery Centers, Medical Spa, Traditional Spa, HCP Owned Clinic, Others) Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033


The US non-invasive aesthetic treatment market size reached USD 6.78 billion in 2023 and is projected to hit around USD 14.66 billion by 2033 with a notable CAGR of 7.9% from 2024 to 2033.

Non-Invasive Aesthetic Treatment Market Size in the US 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • By procedure, the injectable segment held the largest share of the market in 2023.
  • By end-use, the hospitals and surgery centers segment held the largest share of the market in 2023.
  • By end-use, the medical spa segment is expected to capture the largest market share during the forecast period.

US Non-Invasive Aesthetic Treatment Market Overview

The US non-invasive aesthetic treatment market refers to the industry sector encompassing cosmetic procedures and treatments that do not involve surgical incisions or invasive techniques. Skin rejuvenation, body reshaping, and anti-ageing are the main goals of these procedures. When doing non-invasive treatments, one may usually target particular parts of the body with equipment like radiofrequency, ultrasound, or lasers, or minimize the appearance of wrinkles and fine lines using injectables like Botox and dermal fillers. Because they are less intrusive, uncomfortable, and time-consuming than invasive procedures, non-invasive aesthetic treatments are more widely used.

  • According to the United States Census Bureau, the population of Americans 65 and older increased about five times faster than the nation's overall population during the 100 years between 1920 and 2020. In 2020, the number of senior Americans reached 55.8 million, or 16.8% of the total population of the US.
  • According to Elite Facial Plastic Surgery, in the US, Botox is currently the most popular minimally invasive cosmetic surgery. Its popularity has increased recently. Annually, the number of Botox treatments rose by over 459% between 2000 and 2020.

Growth Factors

  • There has been a growing societal acceptance of aesthetic treatments, with a rising demand for procedures that enhance appearance without the need for surgery. People are seeking non-invasive alternatives to address concerns such as wrinkles, fine lines, and skin imperfections.
  • Ongoing advancements in medical and aesthetic technologies have led to the development of more sophisticated and effective non-invasive procedures. Innovations in lasers, radiofrequency, ultrasound, and other technologies contribute to improved outcomes and patient satisfaction.
  • Increased awareness about available non-invasive treatments and better education about their benefits and potential risks have played a role in the market's expansion. As people become more informed, they are more likely to consider non-invasive options.

US Non-Invasive Aesthetic Treatment Market Dynamics

Drivers

Rising interest of individuals in modeling and aviation career

A few sectors, like modeling and flying, have a direct connection to human attractiveness on the outside. A person wishing to work in these fields must meet certain requirements regarding appearance. The airline has requirements for height, skin tone, and body type for applicants seeking to become flight attendants. Applications from applicants with noticeable physical scars or tattoos are frequently denied.

Individuals who choose to pursue these professional paths make every effort to meet the standards. Many people would rather have cosmetic procedures done, but the recovery period and possibility of suture scars from operations frequently prevent them from doing so. In this case, non-invasive aesthetic treatments are the ideal option since they can get around these problems. Thus, this is expected to drive the U.S. non-invasive aesthetic treatment market during the forecast period.

Rising disposable income and technological advancements

Higher disposable income levels among consumers allow for increased spending on aesthetic treatments and procedures. As people become more financially able to invest in their appearance and well-being, the demand for non-invasive aesthetic treatments grows. Constant innovations in non-invasive aesthetic technologies, such as laser therapy, radiofrequency, ultrasound, and cryolipolysis, have expanded treatment options, improved efficacy, and reduced downtime for patients. These technological advancements attract more consumers seeking safer and more effective cosmetic procedures.

Restraint

Risk of complications during treatment

Although non-invasive cosmetic procedures are straightforward and reliable, even with skilled injectors, issues can sometimes arise. Ensuring the patient's safety throughout treatment is the first and foremost aim of any given treatment. Complications including erythema, discomfort, and bruising are possible with some non-invasive cosmetic procedures such as BONT and soft tissue fillers. Erythema, burning sensations, and irritation are often reported side effects of chemical peels.

Furthermore, if the filler is injected into a blood artery rather than under the skin, it might obstruct blood flow. Depending on the location of the filler injection, the obstruction may change in certain situations. If it has impacted the skin, there may be cuts or skin loss if it has impacted the eye, blindness or vision loss may result. Thus, this is expected to hamper the US non-invasive aesthetic treatment market over the forecast period.

Opportunity

High disposable income

The demand for beauty treatments is anticipated to rise in tandem with the growing number of individuals over 50 who have high spending power. People are now fixated on looking young because of today's society. People's attention has shifted as a result to the body as a means of self-expression. High earners are paying large sums of money to slow down or perhaps stop the ageing process.

People who are older than fifty are interested in skin-wrinkle reduction procedures. Additionally, as people in this age group have substantial discretionary incomes, they are spending more on a variety of opulent activities, including non-invasive aesthetic procedures. Thus, the increasing disposable income is expected to offer a lucrative opportunity for the U.S. non-invasive aesthetic treatment market during the projected period.

Procedure Insights

The injectable segment dominated the U.S. non-invasive aesthetic treatment market in 2023. Patients choose injectables because they offer a rapid and comparatively painless method of reducing wrinkles and fine lines. To enhance lips and cheekbones and provide the look of youth, dermal fillers are frequently utilized. It is anticipated that the market for injectables will rise as the world's population ages, propelling the segment's revenue growth.

The skin rejuvenation segment is expected to grow significantly during the forecast period. Skin rejuvenation treatments aim to enhance the appearance and health of the skin, addressing issues such as wrinkles, fine lines, pigmentation, and texture irregularities. The growing consumer awareness is expected to propel the segment's growth.

With an aging population and increasing emphasis on maintaining youthful appearances, there is a rising demand for non-invasive treatments that can address signs of aging such as wrinkles, fine lines, and skin laxity. Skin rejuvenation procedures, such as laser therapy, microdermabrasion, and chemical peels, offer effective solutions for improving skin tone, texture, and elasticity without the need for surgery or downtime.

Advances in medical technology have led to the development of innovative skin rejuvenation devices and techniques that deliver superior results with minimal discomfort and downtime. Cutting-edge technologies such as laser skin resurfacing, radiofrequency micro needling, and intense pulsed light (IPL) therapy enable healthcare providers to customize treatments based on patients' unique skin concerns and desired outcomes.

End Use Insights

The hospitals & surgery centers segment held the largest share of the U.S. non-invasive aesthetic treatment market in 2023. Hospitals and surgery centers often take a multidisciplinary approach to aesthetic care. This may involve collaboration between dermatologists, plastic surgeons, aestheticians, and other healthcare professionals to provide comprehensive treatment plans.

Moreover, hospitals and surgery centers are equipped to provide comprehensive recovery and post-procedure care for patients undergoing non-invasive aesthetic treatments. This includes access to medical facilities and personnel in case of any unforeseen complications. Thereby, driving the segment growth.

The medical spa segment is expected to grow at the fastest pace during the forecast period. Medical spas typically offer a variety of non-invasive aesthetic treatments, including injectables (e.g., Botox, dermal fillers), laser therapies, chemical peels, microdermabrasion, and other skin rejuvenation procedures. The availability of a broad range of services attracts a diverse clientele seeking different solutions for their aesthetic concerns.

In addition, medical spas often invest in state-of-the-art technologies and equipment for non-invasive treatments. This includes laser devices, radiofrequency machines, and other advanced technologies that contribute to effective and efficient procedures.

Recent Developments

  • In January 2023, at the 24th International Master Course on Aging Science (IMCAS) World Congress, Allergan Aesthetics, an AbbVie business, debuted their immersive experience, "Discover your 360°." This customer-centric strategy encourages innovation and offers state-of-the-art tools and solutions to meet practitioners' and patients' immediate and long-term aesthetic demands.

U.S. Non-Invasive Aesthetic Treatment Market Companies

  • Galderma S.A.
  • Allergen
  • El. En. SpA
  • Alma Lasers
  • Johnson & Johnson
  • Cynosure
  • Solta Medical
  • Syneron Candela
  • Lumenis
  • Merz Pharma

Segments Covered in the Report

By Procedure

  • Injectable
    • Polymer Filler
    • Collagen
    • Botulinum Toxin
    • Hyaluronic Acid
    • Calcium Hydroxylapatite
  • Skin Rejuvenation
    • Laser Skin Resurfacing
    • Chemical Peel
    • Photo-rejuvenation
  • Others
    • Hair Removal
    • Sclerotherapy
    • Non-surgical Fat Reduction
    • Cellulite Treatment

By End Use

  • Hospitals & Surgery Centers
  • Medical Spa
  • Traditional Spa
  • HCP Owned Clinic
  • Others

Frequently Asked Questions

How big is the US non-iInvasive aesthetic treatment industry?
The US non-iInvasive aesthetic treatment market size is expected to increase USD 14.66 billion by 2033 from USD 6.78 billion in 2023.
What will be the CAGR of US non-iInvasive aesthetic treatment industry?
The US non-iInvasive aesthetic treatment market will register growth rate of 7.9% between 2024 and 2033.
Who are the prominent players operating in the US non-iInvasive aesthetic treatment market?
The major players operating in the US non-iInvasive aesthetic treatment market are Galderma S.A., Allergen, El. En. SpA, Alma Lasers, Johnson & Johnson, Cynosure, Solta Medical, Syneron Candela, Lumenis, Merz Pharma and Others.
Which are the driving factors of the US non-iInvasive aesthetic treatment market?
The driving factors of the US non-iInvasive aesthetic treatment market are the rising interest of individuals in modeling and aviation career and rising disposable income and technological advancements.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 6000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample